...
首页> 外文期刊>Stem cells translational medicine. >Phenotypic and Functional Characterization of Müller Glia Isolated from Induced Pluripotent Stem Cell‐Derived Retinal Organoids: Improvement of Retinal Ganglion Cell Function upon Transplantation
【24h】

Phenotypic and Functional Characterization of Müller Glia Isolated from Induced Pluripotent Stem Cell‐Derived Retinal Organoids: Improvement of Retinal Ganglion Cell Function upon Transplantation

机译:从诱导的多能干细胞衍生的视网膜类生物体分离的Müller胶质细胞的表型和功能表征:移植后视网膜神经节细胞功能的改善。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Glaucoma is one of the leading causes of blindness, and there is an ongoing need for new therapies. Recent studies indicate that cell transplantation using Müller glia may be beneficial, but there is a need for novel sources of cells to provide therapeutic benefit. In this study, we have isolated Müller glia from retinal organoids formed by human induced pluripotent stem cells (hiPSCs) in vitro and have shown their ability to partially restore visual function in rats depleted of retinal ganglion cells by NMDA. Based on the present results, we suggest that Müller glia derived from retinal organoids formed by hiPSC may provide an attractive source of cells for human retinal therapies, to prevent and treat vision loss caused by retinal degenerative conditions.
机译:青光眼是失明的主要原因之一,并且不断需要新的疗法。最近的研究表明,使用Müller胶质细胞进行细胞移植可能是有益的,但是需要新的细胞来源来提供治疗益处。在这项研究中,我们从人诱导的多能干细胞(hiPSC)体外形成的视网膜类动物体中分离了Müller胶质细胞,并显示了它们能够在NMDA耗尽视网膜神经节细胞的大鼠中部分恢复视觉功能。根据目前的结果,我们认为源自hiPSC形成的视网膜类器官的Müller胶质细胞可能为人类视网膜治疗提供有吸引力的细胞来源,以预防和治疗由视网膜退行性疾病引起的视力丧失。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号